BIO-TECHNE Corp — Director's Dealing 2017

Jul 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2017-07-01

Reporting Person: Eansor Norman David (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-01	Common Stock	F	534.00	$117.50	Disposed	3402.00	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Units	$		Common Stock (1500.00)	1500.00	Direct
Restricted Stock Units	$		Common Stock (2287.00)	2287.00	Direct
Stock Option (Right to Buy)	$108.49	2022-08-07	Common Stock (12500.00)	12500.00	Direct
Stock Option (Right to Buy)	$108.49	2022-08-07	Common Stock (9375.00)	9375.00	Direct
Stock Option (Right to Buy)	$94.35	2021-08-12	Common Stock (15000.00)	15000.00	Direct
Stock Options (Right to buy)	$106.59	2023-08-18	Common Stock (18819.00)	18819.00	Direct
Stock Options (Right to buy)	$106.59	2023-08-18	Common Stock (14114.00)	14114.00	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F4: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F5: 3,125 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.

F6: 3,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.

F7: Vests 4,705 shares on 8/18/17, 8/18/18, and 8/18/19 and 4,704 shares on 8/18/20.